| Dr Edward C Yang, MD | |
|
7901 Broadway, Elmhurst, NY 11373-1329 | |
| (718) 334-3379 | |
| (718) 334-5057 |
| Full Name | Dr Edward C Yang |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 42 Years |
| Location | 7901 Broadway, Elmhurst, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992763767 | NPI | - | NPPES |
| 01055792 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 154675-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vns Of Ny Home Care Chha | New york, NY | Home health agency |
| Mount Sinai Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore Medical Group Of The Mount Sinai School Of Medicine | 8921999087 | 270 |
News Archive
A life-sized artificial human lung created at the Technion-Israel Institute of Technology is the first diagnostic tool for understanding in real time how tiny particles move and behave in the deepest part of the human lungs (alveolar tissue).
School nurses reach 98 percent of the 50,000,000 students in U.S. public schools, grades k-12, and are uniquely positioned to facilitate the early diagnosis of serious medical conditions such as primary immunodeficiency (PI).
Using yeast cells, a group of researchers at the University of Gothenburg, Sweden, has taken a groundbreaking step towards being able to build complex systems in the future where the body's own cells help to keep us healthy.
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
› Verified 4 days ago
| Entity Name | North Shore Medical Group Of The Mount Sinai School Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275640609 PECOS PAC ID: 8921999087 Enrollment ID: O20040320000412 |
News Archive
A life-sized artificial human lung created at the Technion-Israel Institute of Technology is the first diagnostic tool for understanding in real time how tiny particles move and behave in the deepest part of the human lungs (alveolar tissue).
School nurses reach 98 percent of the 50,000,000 students in U.S. public schools, grades k-12, and are uniquely positioned to facilitate the early diagnosis of serious medical conditions such as primary immunodeficiency (PI).
Using yeast cells, a group of researchers at the University of Gothenburg, Sweden, has taken a groundbreaking step towards being able to build complex systems in the future where the body's own cells help to keep us healthy.
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
› Verified 4 days ago
| Entity Name | Mount Sinai Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013948595 PECOS PAC ID: 1153219431 Enrollment ID: O20040421000437 |
News Archive
A life-sized artificial human lung created at the Technion-Israel Institute of Technology is the first diagnostic tool for understanding in real time how tiny particles move and behave in the deepest part of the human lungs (alveolar tissue).
School nurses reach 98 percent of the 50,000,000 students in U.S. public schools, grades k-12, and are uniquely positioned to facilitate the early diagnosis of serious medical conditions such as primary immunodeficiency (PI).
Using yeast cells, a group of researchers at the University of Gothenburg, Sweden, has taken a groundbreaking step towards being able to build complex systems in the future where the body's own cells help to keep us healthy.
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
› Verified 4 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477932275 PECOS PAC ID: 2264691070 Enrollment ID: O20150811003333 |
News Archive
A life-sized artificial human lung created at the Technion-Israel Institute of Technology is the first diagnostic tool for understanding in real time how tiny particles move and behave in the deepest part of the human lungs (alveolar tissue).
School nurses reach 98 percent of the 50,000,000 students in U.S. public schools, grades k-12, and are uniquely positioned to facilitate the early diagnosis of serious medical conditions such as primary immunodeficiency (PI).
Using yeast cells, a group of researchers at the University of Gothenburg, Sweden, has taken a groundbreaking step towards being able to build complex systems in the future where the body's own cells help to keep us healthy.
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward C Yang, MD 7901 Broadway, Elmhurst, NY 11373-1329 Ph: (718) 334-3379 | Dr Edward C Yang, MD 7901 Broadway, Elmhurst, NY 11373-1329 Ph: (718) 334-3379 |
News Archive
A life-sized artificial human lung created at the Technion-Israel Institute of Technology is the first diagnostic tool for understanding in real time how tiny particles move and behave in the deepest part of the human lungs (alveolar tissue).
School nurses reach 98 percent of the 50,000,000 students in U.S. public schools, grades k-12, and are uniquely positioned to facilitate the early diagnosis of serious medical conditions such as primary immunodeficiency (PI).
Using yeast cells, a group of researchers at the University of Gothenburg, Sweden, has taken a groundbreaking step towards being able to build complex systems in the future where the body's own cells help to keep us healthy.
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery. These medications are used to treat a variety of inflammatory diseases, including rheumatoid arthritis, and better timing of withdrawal prior to surgery might minimize the risk of disease flares.
› Verified 4 days ago
Richard Ghillani, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 79 01 Broadway, Room A1 - 9, Elmhurst, NY 11373 Phone: 718-334-4952 Fax: 718-334-4815 | |
Sachin Gopaldas Gujarathi, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7901 Broadway, Elmhurst, NY 11373 Phone: 347-659-2704 | |
Daniel Richard O'connor, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9438 58th Ave, Unit G-3, Elmhurst, NY 11373 Phone: 718-393-3900 Fax: 718-393-3999 | |
Dr. Rohit Hasija, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7901 Broadway # D4-55, Elmhurst, NY 11373 Phone: 718-334-3378 Fax: 718-334-5057 | |
Thomas H. Witschi, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 79 01 Broadway, Room A1-9, Elmhurst, NY 11373 Phone: 718-334-4952 Fax: 718-334-4815 | |
Nityananda Rao Jakkula, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7901 Broadway Dept Of, Elmhurst, NY 11373 Phone: 662-394-5006 | |
Dr. Kenneth Edwin Seslowe, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 40-33 76th St., Elmhurst, NY 11373 Phone: 718-898-5470 Fax: 718-651-7294 |